Industry News
Thank you, Darling – UK spends on tech
UK taxes rich, spends on tech investment fund [ + ]
Australian biotech market today 22.04.09
Genetic Technologies, Circadian, Bionomics, Ambri, Hexima, LCT, Pharmaxis, Cellestis, AIC [ + ]
Redundancy begets complexity
A study into two rare metabolic disorders shows that what may look like simple recessive or semi-dominant patterns of inheritance, may actually involve complex interactions with several other genes. [ + ]
Bionomics targets throat cancer
Throat cancer added to list of targets for VDA, Celera developing proteomics-based lung cancer diagnostic [ + ]
Solid performance for biotech: PwC
Latest PwC BioForum report has unexpected good news, but fundamentals are unchanged [ + ]
Australian biotech market today 21.04.09
Neuren, ChemGenex, Novogen, Biota, Alchemia, Impedimed, Sirtex [ + ]
QRxPharma hits on right dose
QRxPharma completes Phase III dose pilot for opioids [ + ]
Progen targets epigenetics
Progen working on polyamine analogues for DNA demethylases, cell proliferation [ + ]
Virionyx goes Innate
NZ company changes name, repositions strategy [ + ]
Fight of the honeybees
Spanish researchers may have found a cure for honeybee colony collapse disorder [ + ]
Australian biotech market today 15.04.09
Acrux, Atcor, Cellestis, Pharmaxis, Mesoblast, Circadian, Alchemia [ + ]
Ovature trial cut short
Novogen’s Marshall Edwards subsidiary to wind up ovarian cancer trial early [ + ]
Acuvax cashes in RESprotect
Acuvax divests small holding in German developer of pancreatic cancer drug [ + ]
Antarctic Ice Bridge Due to Collapse Within Days
Massive ice shelf withinin days of being separated from the Antarctic mainland. [ + ]
